The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
Yunshu Su,1 Xiaoli Wang,1,2 Jun Li,1 Junming Xu,3 Lijun Xu1 1Department of Cardiothoracic Surgery, 2Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 3Department of General Surgery, Shanghai First People’s...
Main Authors: | Su Y, Wang X, Li J, Xu J, Xu L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/the-clinicopathological-significance-and-drug-target-potential-of-fhit-peer-reviewed-article-DDDT |
Similar Items
-
The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
by: Wu X, et al.
Published: (2016-02-01) -
Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review
by: Huang R, et al.
Published: (2015-09-01) -
Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis
by: Zhang Y, et al.
Published: (2017-06-01) -
Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review
by: Yu Q, et al.
Published: (2015-04-01) -
Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
by: Xu L, et al.
Published: (2015-06-01)